RIVIAN AUTOMOTIVE INC-A (RIVN)

US76954A1034 - Common Stock

13.83  +0.77 (+5.9%)

After market: 13.85 +0.02 (+0.14%)

Fundamental Rating

2

Taking everything into account, RIVN scores 2 out of 10 in our fundamental rating. RIVN was compared to 42 industry peers in the Automobiles industry. While RIVN seems to be doing ok healthwise, there are quite some concerns on its profitability. RIVN is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

RIVN had negative earnings in the past year.
RIVN had a negative operating cash flow in the past year.
RIVN had negative earnings in each of the past 5 years.
RIVN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

RIVN has a Return On Assets of -38.73%. This is in the lower half of the industry: RIVN underperforms 73.81% of its industry peers.
RIVN has a Return On Equity of -93.64%. This is in the lower half of the industry: RIVN underperforms 64.29% of its industry peers.
Industry RankSector Rank
ROA -38.73%
ROE -93.64%
ROIC N/A
ROA(3y)-30.39%
ROA(5y)-25.9%
ROE(3y)-44.13%
ROE(5y)-35.34%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for RIVN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

RIVN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RIVN has more shares outstanding
RIVN has a worse debt/assets ratio than last year.

2.2 Solvency

RIVN has an Altman-Z score of -1.53. This is a bad value and indicates that RIVN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.53, RIVN is in line with its industry, outperforming 45.24% of the companies in the same industry.
RIVN has a Debt/Equity ratio of 0.93. This is a neutral value indicating RIVN is somewhat dependend on debt financing.
RIVN's Debt to Equity ratio of 0.93 is on the low side compared to the rest of the industry. RIVN is outperformed by 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Altman-Z -1.53
ROIC/WACCN/A
WACC11.21%

2.3 Liquidity

RIVN has a Current Ratio of 5.09. This indicates that RIVN is financially healthy and has no problem in meeting its short term obligations.
RIVN has a better Current ratio (5.09) than 97.62% of its industry peers.
RIVN has a Quick Ratio of 3.70. This indicates that RIVN is financially healthy and has no problem in meeting its short term obligations.
RIVN has a Quick ratio of 3.70. This is amongst the best in the industry. RIVN outperforms 97.62% of its industry peers.
Industry RankSector Rank
Current Ratio 5.09
Quick Ratio 3.7

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 10.29% over the past year.
Looking at the last year, RIVN shows a very strong growth in Revenue. The Revenue has grown by 20.33%.
EPS 1Y (TTM)10.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
Revenue 1Y (TTM)20.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.63%

3.2 Future

Based on estimates for the next years, RIVN will show a small growth in Earnings Per Share. The EPS will grow by 6.54% on average per year.
RIVN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 33.84% yearly.
EPS Next Y16.96%
EPS Next 2Y19.98%
EPS Next 3Y15.04%
EPS Next 5Y6.54%
Revenue Next Year5.44%
Revenue Next 2Y7.4%
Revenue Next 3Y20.62%
Revenue Next 5Y33.84%

3.3 Evolution

0

4. Valuation

4.1 Price/Earnings Ratio

RIVN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RIVN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as RIVN's earnings are expected to grow with 15.04% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.98%
EPS Next 3Y15.04%

0

5. Dividend

5.1 Amount

No dividends for RIVN!.
Industry RankSector Rank
Dividend Yield N/A

RIVIAN AUTOMOTIVE INC-A

NASDAQ:RIVN (12/20/2024, 10:26:15 PM)

After market: 13.85 +0.02 (+0.14%)

13.83

+0.77 (+5.9%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-19 2025-02-19/amc
Inst Owners49.42%
Inst Owner Change-5.26%
Ins Owners0.47%
Ins Owner Change-0.02%
Market Cap14.12B
Analysts73.71
Price Target15.26 (10.34%)
Short Float %20.35%
Short Ratio3.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)1.88%
Min EPS beat(2)-4.76%
Max EPS beat(2)8.51%
EPS beat(4)1
Avg EPS beat(4)-0.38%
Min EPS beat(4)-4.76%
Max EPS beat(4)8.51%
EPS beat(8)5
Avg EPS beat(8)8.75%
EPS beat(12)8
Avg EPS beat(12)5.8%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.86%
Min Revenue beat(2)-13.38%
Max Revenue beat(2)-0.34%
Revenue beat(4)2
Avg Revenue beat(4)-2.53%
Min Revenue beat(4)-13.38%
Max Revenue beat(4)2.18%
Revenue beat(8)3
Avg Revenue beat(8)-1.82%
Revenue beat(12)4
Avg Revenue beat(12)-4.5%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-11.16%
PT rev (3m)-16.74%
EPS NQ rev (1m)5.53%
EPS NQ rev (3m)17.86%
EPS NY rev (1m)-1.28%
EPS NY rev (3m)-3.79%
Revenue NQ rev (1m)5.18%
Revenue NQ rev (3m)-10.13%
Revenue NY rev (1m)-1.05%
Revenue NY rev (3m)-3.66%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 3.1
P/FCF N/A
P/OCF N/A
P/B 2.39
P/tB 2.39
EV/EBITDA N/A
EPS(TTM)-4.71
EYN/A
EPS(NY)-2.74
Fwd EYN/A
FCF(TTM)-5.01
FCFYN/A
OCF(TTM)-3.92
OCFYN/A
SpS4.46
BVpS5.78
TBVpS5.78
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -38.73%
ROE -93.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-30.39%
ROA(5y)-25.9%
ROE(3y)-44.13%
ROE(5y)-35.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 102.68%
Cap/Sales 24.43%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.09
Quick Ratio 3.7
Altman-Z -1.53
F-Score4
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)410.04%
Cap/Depr(5y)1439.23%
Cap/Sales(3y)1122.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.65%
EPS Next Y16.96%
EPS Next 2Y19.98%
EPS Next 3Y15.04%
EPS Next 5Y6.54%
Revenue 1Y (TTM)20.33%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-34.63%
Revenue Next Year5.44%
Revenue Next 2Y7.4%
Revenue Next 3Y20.62%
Revenue Next 5Y33.84%
EBIT growth 1Y8.72%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year44.89%
EBIT Next 3Y20.61%
EBIT Next 5Y17.52%
FCF growth 1Y17.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y14.62%
OCF growth 3YN/A
OCF growth 5YN/A